- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07946471
A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes
This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Izaak Woodley
- E-mail: izaakwoodley@thecollagen.co
Locais de estudo
-
-
Nevada
-
Las Vegas, Nevada, Estados Unidos, 89101
- Citruslabs
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Adults aged 18-55 years at the time of enrollment.
- BMI between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
- Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
- Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
- Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
- In good general health.
- Resides in the United States.
Exclusion Criteria:
- Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
- Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
- Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
- Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
- Currently testing, or plan to in the next 6 weeks, a product for another research study.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Glow Shakes Premium Collagen Meal Replacement Arm
|
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Body Weight
Prazo: Baseline to Week 6
|
Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
|
Change in Body Fat Percentage
Prazo: Baseline to Week 6
|
Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Self-Reported Weight Management Score
Prazo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hunger Intensity
Prazo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Satiety Duration
Prazo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Food Craving Score
Prazo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced) |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Skin Health Score
Prazo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hair Health Score
Prazo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Nail Health Score
Prazo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Gut Comfort and Digestive Symptom Score
Prazo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Participant-Reported Product Satisfaction
Prazo: Week 6
|
Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Product Tolerability
Prazo: Week 6
|
Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Overall Product Experience
Prazo: Week 6
|
Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire |
Week 6
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- THECO-22384
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .